Globus Medical (GMED) reported Q1 non-GAAP earnings late Thursday of $0.68 per diluted share, up from $0.63 a year earlier.

Two analysts polled by FactSet, on average, expected $0.77.

Net sales for the quarter ended March 31 fell to $598.1 million from $606.7 million a year earlier.

Analysts expected $625.9 million.

For 2025, the company said it cut its non-GAAP EPS outlook to $3 to $3.30 from $3.10 to $3.40 previously and reaffirmed revenue guidance in the range of $2.80 billion to $2.90 billion.

Analysts are looking for $3.28 and $2.68 billion, respectively.

Shares of Globus Medical fell more than 16% in Thursday's after-hours session.